1-5 of 5
blalock-taussig shunt
Close
Sort by
Journal Articles

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

Mrinal M. Patnaik, MBBS, Emnet A Wassie, MD, Terra L Lasho, PhD, Curtis A. Hanson, MD, Rhett Ketterling, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2014) 124 (21): 1932.
https://doi.org/10.1182/blood.V124.21.1932.1932
Published: 2014
Journal Articles

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Erik I. Tucker, PhD, Ulla M Marzec, MS, Philberta Y Leung, PhD, Stephen R Hanson, PhD, Prof., Norah G Verbout, PhD, Sawan Hurst, MS, Owen J.T. McCarty, PhD, David Gailani, MD, Andras Gruber, MD
Journal: Blood
Blood (2011) 118 (21): 1173.
https://doi.org/10.1182/blood.V118.21.1173.1173
Published: 2011
Journal Articles

Moderate Pharmacological Platelet Count Reduction Limits Thrombus Formation without Hemostatic Impairment in Primates

Erik I Tucker, Ulla M Marzec, Sawan Hurst, András Gruber, MD, Stephen R Hanson, PhD
Journal: Blood
Blood (2008) 112 (11): 1033.
https://doi.org/10.1182/blood.V112.11.1033.1033
Published: 2008
Journal Articles

Retrospective Analysis of the Minimum Dosage Requirements for Enoxaparin in Neonates with Thromboembolic Disease.

Fiona A. Punter, Ph.D, Patricia J. McCusker, M.D., Mary M.K. Seshia, M.D., Sara J. Israels, M.D., Blair W. Seifert, Pharm.D.
Journal: Blood
Blood (2004) 104 (11): 1770.
https://doi.org/10.1182/blood.V104.11.1770.1770
Published: 2004
Journal Articles

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4 + CD56 + blastic tumors of skin

Brief Report
Marco Herling, Michael A. Teitell, Rhine R. Shen, L. Jeffrey Medeiros, Dan Jones
Journal: Blood
Blood (2003) 101 (12): 5007–5009.
https://doi.org/10.1182/blood-2002-10-3297
Published: 2003